223 related articles for article (PubMed ID: 30467094)
1. Functional MIF promoter haplotypes modulate Th17-related cytokine expression in peripheral blood mononuclear cells from control subjects and rheumatoid arthritis patients.
Hernández-Palma LA; García-Arellano S; Bucala R; Llamas-Covarrubias MA; De la Cruz-Mosso U; Oregon-Romero E; Cerpa-Cruz S; Parra-Rojas I; Plascencia-Hernández A; Muñoz-Valle JF
Cytokine; 2019 Mar; 115():89-96. PubMed ID: 30467094
[TBL] [Abstract][Full Text] [Related]
2. Th1/Th17 Cytokine Profile is Induced by Macrophage Migration Inhibitory Factor in Peripheral Blood Mononuclear Cells from Rheumatoid Arthritis Patients.
García-Arellano S; Hernández-Palma LA; Bucala R; Hernández-Bello J; De la Cruz-Mosso U; García-Iglesias T; Cerpa-Cruz S; Padilla-Gutiérrez JR; Valle Y; Soñanez-Organis JG; Parra-Rojas I; Pereira-Suárez AL; Muñoz-Valle JF
Curr Mol Med; 2018; 18(10):679-688. PubMed ID: 30698113
[TBL] [Abstract][Full Text] [Related]
3. MIF promotes a differential Th1/Th2/Th17 inflammatory response in human primary cell cultures: Predominance of Th17 cytokine profile in PBMC from healthy subjects and increase of IL-6 and TNF-α in PBMC from active SLE patients.
De la Cruz-Mosso U; García-Iglesias T; Bucala R; Estrada-García I; González-López L; Cerpa-Cruz S; Parra-Rojas I; Gámez-Nava JI; Pérez-Guerrero EE; Muñoz-Valle JF
Cell Immunol; 2018 Feb; 324():42-49. PubMed ID: 29397904
[TBL] [Abstract][Full Text] [Related]
4. Macrophage migration inhibitory factor polymorphisms are a potential susceptibility marker in systemic sclerosis from southern Mexican population: association with MIF mRNA expression and cytokine profile.
Baños-Hernández CJ; Navarro-Zarza JE; Bucala R; Hernández-Bello J; Parra-Rojas I; Ramírez-Dueñas MG; García-Arellano S; Hernández-Palma LA; Machado-Sulbarán AC; Muñoz-Valle JF
Clin Rheumatol; 2019 Jun; 38(6):1643-1654. PubMed ID: 30747392
[TBL] [Abstract][Full Text] [Related]
5. The Novel Role of MIF in the Secretion of IL-25, IL-31, and IL-33 from PBMC of Patients with Rheumatoid Arthritis.
García-Arellano S; Hernández-Palma LA; Cerpa-Cruz S; Sánchez-Zuno GA; Herrera-Godina MG; Muñoz-Valle JF
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443554
[TBL] [Abstract][Full Text] [Related]
6. Macrophage migration inhibitory factor (MIF): genetic evidence for participation in early onset and early stage rheumatoid arthritis.
Llamas-Covarrubias MA; Valle Y; Bucala R; Navarro-Hernández RE; Palafox-Sánchez CA; Padilla-Gutiérrez JR; Parra-Rojas I; Bernard-Medina AG; Reyes-Castillo Z; Muñoz-Valle JF
Cytokine; 2013 Mar; 61(3):759-65. PubMed ID: 23402792
[TBL] [Abstract][Full Text] [Related]
7. Macrophage migration inhibitory factor promoter polymorphisms are associated with disease activity in rheumatoid arthritis patients from Southern Mexico.
Santoscoy-Ascencio G; Baños-Hernández CJ; Navarro-Zarza JE; Hernández-Bello J; Bucala R; López-Quintero A; Valdés-Alvarado E; Parra-Rojas I; Illades-Aguiar B; Muñoz-Valle JF
Mol Genet Genomic Med; 2020 Jan; 8(1):e1037. PubMed ID: 31701681
[TBL] [Abstract][Full Text] [Related]
8. Expression of MIF and TNFA in psoriatic arthritis: relationship with Th1/Th2/Th17 cytokine profiles and clinical variables.
Bautista-Herrera LA; De la Cruz-Mosso U; Morales-Zambrano R; Villanueva-Quintero GD; Hernández-Bello J; Ramírez-Dueñas MG; Martínez-López E; Brennan-Bourdon LM; Baños-Hernández CJ; Muñoz-Valle JF
Clin Exp Med; 2018 May; 18(2):229-235. PubMed ID: 28965181
[TBL] [Abstract][Full Text] [Related]
9. Expression of Transcriptional Factors of T Helper Differentiation (T-bet, GATA-3, RORγt, and FOXP3), MIF Receptors (CD44, CD74, CXCR2, 4, 7), and Th1, Th2, and Th17 Cytokines in PBMC from Control Subjects and Rheumatoid Arthritis Patients.
Hernández DAZ; Chagollán MG; Zuno GAS; Arellano SG; Bello JH; Palma LAH; Cruz SC; Bonilla GM; Nicoletti F; Valle JFM
Curr Mol Med; 2023 Oct; ():. PubMed ID: 37807647
[TBL] [Abstract][Full Text] [Related]
10. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor.
Radstake TR; Sweep FC; Welsing P; Franke B; Vermeulen SH; Geurts-Moespot A; Calandra T; Donn R; van Riel PL
Arthritis Rheum; 2005 Oct; 52(10):3020-9. PubMed ID: 16200611
[TBL] [Abstract][Full Text] [Related]
11. Macrophage migration inhibitory factor upregulates angiogenic factors and correlates with clinical measures in rheumatoid arthritis.
Kim HR; Park MK; Cho ML; Yoon CH; Lee SH; Park SH; Leng L; Bucala R; Kang I; Choe J; Kim HY
J Rheumatol; 2007 May; 34(5):927-36. PubMed ID: 17407222
[TBL] [Abstract][Full Text] [Related]
12. Association of Macrophage Migration Inhibitory Factor Polymorphisms with Total Plasma IgE Levels in Patients with Atopic Dermatitis in Korea.
Kim JS; Choi J; Hahn HJ; Lee YB; Yu DS; Kim JW
PLoS One; 2016; 11(9):e0162477. PubMed ID: 27598332
[TBL] [Abstract][Full Text] [Related]
13. Association of MIF promoter polymorphisms with psoriasis in a Han population in northeastern China.
Wu J; Chen F; Zhang X; Li Y; Ma H; Zhou Y; Jin Y; Wang H; Bai J; Zhang G; Fu S
J Dermatol Sci; 2009 Mar; 53(3):212-5. PubMed ID: 19157791
[TBL] [Abstract][Full Text] [Related]
14. Investigation of MIF gene promoter variations and their haplotypes in the Alzheimer disease in Turkish population.
Sahin K; Rustemoglu A
Nucleosides Nucleotides Nucleic Acids; 2024; 43(4):277-291. PubMed ID: 37665108
[TBL] [Abstract][Full Text] [Related]
15. Association between IL-17A, -17F and MIF polymorphisms predispose to CpG island hyper-methylation in gastric cancer.
Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I; Arisawa T
Int J Mol Med; 2010 Mar; 25(3):471-7. PubMed ID: 20127054
[TBL] [Abstract][Full Text] [Related]
16. Macrophage migration inhibitory factor gene polymorphisms (SNP -173 G>C and STR-794 CATT5-8) confer risk of plaque psoriasis: A case-control study.
Hernández-Bello J; Rodríguez-Puente M; Gutiérrez-Cuevas J; García-Arellano S; Muñoz-Valle JF; Fafutis-Morris M; Villanueva-Quintero DG; Alvarado-Navarro A
J Clin Lab Anal; 2021 Nov; 35(11):e23999. PubMed ID: 34533238
[TBL] [Abstract][Full Text] [Related]
17. Associations between circulating macrophage migration inhibitory factor (MIF) levels and rheumatoid arthritis, and between
Bae SC; Lee YH
Postgrad Med J; 2018 Feb; 94(1108):109-115. PubMed ID: 28912189
[TBL] [Abstract][Full Text] [Related]
18. Effect of polymorphisms of IL-17A, -17F and MIF genes on CpG island hyper-methylation (CIHM) in the human gastric mucosa.
Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Maeda Y; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Hirata I; Arisawa T
Int J Mol Med; 2009 Oct; 24(4):563-9. PubMed ID: 19724898
[TBL] [Abstract][Full Text] [Related]
19. A genetic role for macrophage migration inhibitory factor (MIF) in adult-onset Still's disease.
Wang FF; Huang XF; Shen N; Leng L; Bucala R; Chen SL; Lu LJ
Arthritis Res Ther; 2013; 15(3):R65. PubMed ID: 23721694
[TBL] [Abstract][Full Text] [Related]
20. Association of the genetic variants (-794 CATT5-8 and -173 G > C) of macrophage migration inhibitory factor (MIF) with higher soluble levels of MIF and TNFα in women with breast cancer.
Avalos-Navarro G; Del Toro-Arreola A; Daneri-Navarro A; Quintero-Ramos A; Bautista-Herrera LA; Franco Topete RA; Anaya Macias BU; Javalera Castro DI; Morán-Mendoza AJ; Oceguera-Villanueva A; Topete-Camacho A; Muñoz-Valle JF
J Clin Lab Anal; 2020 May; 34(5):e23209. PubMed ID: 31978276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
